Unicycive Therapeutics, Inc.

8-K Other events Jul 2, 2026 8-K Shareholder vote results Jun 22, 2026 8-K Entered a material agreement Jun 5, 2026 8-K Results of operations (earnings release) May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Director or officer change Apr 6, 2026 8-K Results of operations (earnings release) Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Other events Nov 14, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Other events Oct 28, 2025 8-K Other events Aug 18, 2025 8-K Other events Aug 15, 2025 8-K Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Jul 8, 2025 8-K Results of operations (earnings release); Other events Jun 30, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jun 20, 2025 8-K Other events Jun 10, 2025 8-K Shareholder vote results Jun 9, 2025 8-K Other events May 21, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K/A Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Apr 14, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Other events Jan 7, 2025 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Other events Nov 12, 2024 8-K Other events Sep 25, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Delisting notice or listing-rule failure Jul 15, 2024 8-K Delisting notice or listing-rule failure Jul 15, 2024 8-K Entered a material agreement Jul 2, 2024 8-K Amended charter or bylaws Jun 26, 2024 8-K Regulation FD disclosure Jun 25, 2024 8-K Shareholder vote results Jun 20, 2024